GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and ...
QIAGEN N.V. QGEN recently announced the receipt of emergency use authorization (EUA) from the FDA for its QIAreach SARS CoV-2 Antigen Test. This rapid portable test is designed to address the ...
DURHAM, N.C.--(BUSINESS WIRE)--Baebies, a growth-stage company developing innovative products to enable early disease detection and comprehensive diagnosis, today announced that the U.S. Food & Drug ...
Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...
Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...
Please provide your email address to receive an email when new articles are posted on . Published results showed a preoperative polymerase chain reaction test with advice about minimizing the risk of ...
In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnosis is important for patients and public health to assess the levels of virus and infection risk. Due to the high need for SARS-CoV-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results